Clinical Trials Browser

Adenocarcinoma, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Breast Diseases, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Genital Diseases, Male, Intestinal Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Prostatic Diseases, Prostatic Neoplasms, Skin Diseases, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Nevi and Melanomas, Neuroendocrine Tumors

NCT00062621 2013-02-05

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

Phase 1 Completed

5 enrolled

GenitourinaryPlasma cell

Graft vs Host Disease, Kidney Diseases, Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

NCT00886353 2009-12-31

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Phase 1 Completed

22 enrolled

Genitourinary

Cardiovascular Diseases, Kidney Diseases, Lung Diseases

NCT00001835 2008-03-04

Oxaliplatin in Cancer Patients With Impaired Kidney Function

Phase 1 Completed

60 enrolled

Genitourinary

Kidney Diseases, Kidney Neoplasms, Neoplasm Metastasis, Neoplasms, Renal Insufficiency

Clinical Trials

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

JAVELIN Renal 100

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Oxaliplatin in Cancer Patients With Impaired Kidney Function